| Financial Year |
March 31 2023 |
| Monetary Funds |
726,010,661.49 |
| Held-for-trading Financial Assets |
140,244,520.54 |
| Notes Receivable |
18,601,850.22 |
| Accounts Receivable |
1,072,681,508.30 |
| Advances to Suppliers |
15,362,410.90 |
| Other Receivables |
56,257,096.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
238,384.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,920,552.20 |
| Total Current Assets |
4,079,471,513.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
159,706,763.24 |
| Investment Properties |
39,437,589.86 |
| Fixed Assetes |
560,111,605.23 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,576,615.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
31,380,148.93 |
| Deferred Income Tax Assets |
128,330,122.01 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,259,565,314.45 |
| Total Assets |
5,339,036,827.99 |
| Short-Term Loans |
150,075,972.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,248,596,997.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,849,036.48 |
| Taxes Payable |
100,170,540.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
152,605,202.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,085,496.41 |
| Other Current Liabilities |
17,297,396.13 |
| Sub-Total of Current Liabilities |
2,001,133,810.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,376,134.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,235,282.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,419,433.84 |
| Total Liabilities |
2,013,553,244.43 |
| Paid-In Capital(Or Share Stock) |
467,576,378.00 |
| Capital Surplus |
841,319,200.71 |
| Surplus Reserve |
208,937,621.74 |
| LESS:Treasury Stock |
71,945,913.60 |
| Undistributed Profits |
1,821,296,408.86 |
| Minority Stockholder's Interest |
58,299,887.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,267,183,695.71 |
| Owner's Equity（Stockholder's Equity） |
3,325,483,583.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,339,036,827.99 |
